Drummond, Stoddart, Torrance. Metodos para evaluacion economica de los programas de atencion de la salud. Ediciones Diaz de Santos SA. Madrid, 1991. 

Sacristan , Badia, Rovira. Farmacoeconomica: Evaluacion economica de medicamentos. Editores Medicos, Madrid, 1995. 

Stronks K, Strijbis AM, Wendte JF, Gunning-Schepers LJ. Who should decide? Qualitative analysis of panel data from public, patients, healthcare professionals, and insurers on priorities in health care. BMJ 1997, Jul 12;315(7100):92-6.
http://www.bmj.com/cgi/content/full/315/7100/92

Blumenthal D. Health care reform at the close of the 20th century. New England Journal of Medicine, 1999, 340 (24):1916 
No está disponible en el Internet, ir a la biblioteca! 

Byford S, Raftery J. Perspectives in economic evaluation. BMJ 1998 May 16;316(7143):1529-30.
http://www.bmj.com/cgi/content/full/316/7143/1529

Gould MK, Dembitzer AD, Sanders GD, Garber AM. Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness Analysis. Annals of Internal Medicine. 130(10):789-799, May 18, 1999
http://acp.edoc.com/issues/v130n10/full/199905180-00002.html

Greenhalgh T. How to read a paper: Papers that tell you what things cost (economic analyses). BMJ 1997;315:596-599 (6 September).
http://www.bmj.com/cgi/content/full/315/7108/596

Torgerson D, Raftery J. Economic Notes: Measuring outcomes in economic evaluations BMJ 1999; 318: 1413. (22 May) 
http://www.bmj.com/cgi/content/full/318/7195/1413

Briggs A. Economics notes: Handling uncertainty in economic evaluation. BMJ 1999 Jul 10;319(7202):120
http://www.bmj.com/cgi/content/full/319/7202/120

Palmer S, Byford S, Raftery J. Economics notes: types of economic evaluation. BMJ 1999 May 15;318(7194):1349
http://www.bmj.com/cgi/content/full/318/7194/1349

Drummond R, Luft HS. Pharmacoeconomic Analyses: Making Them Transparent, Making Them Credible. JAMA, 2000; Vol. 283 No. 16, April 26, 2000: 2158.
http://jama.ama-assn.org/issues/v283n16/ffull/jed00027.html

Drummond MF, Richardson SW, O'Brien BJ, Levine M, Heyland D. Users' Guides to the Medical Literature: XIII. How to Use an Article on Economic Analysis of Clinical Practice: A. Are the Results of the Study Valid?
JAMA. 277(19):1552-1557, 1997 May 21 
No está disponible en el Internet, ir a la biblioteca! 

O'Brien BJ, Heyland D, Richardson SW, Levine M, Drummond MF. Users' Guides to the Medical Literature: XIII. How to Use an Article on Economic Analysis of Clinical Practice: B. What Are the Results and Will They Help Me in Caring for My Patients? JAMA. 277(22):1802-1806, 1997 June. 
No está disponible en el Internet, ir a la biblioteca! 

Perry, Seymour MD, MACP. Thamer, Mae PhD. Medical Innovation and the Critical Role of Health Technology Assessment. [Editorial] JAMA.282(19):1869?1872, November 17, 1999. 
http://jama.ama-assn.org/issues/v282n19/rfull/jco90049.html

Norheim, Ole Frithjof associate professor. Healthcare rationing - are additional criteria needed for assessing evidence based clinical practice guidelines-[Miscellaneous Article]. BMJ. 319(7222):1426-1429, November 27, 1999. 
http://bmj.com/cgi/content/full/319/7222/1426
 
 
 

Canadian Coordinating Office for Health Technology Assessment. Guidelines for economic evaluation of pharmaceuticals: Canada. 2nd ed. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997
http://www.ccohta.ca/newweb/pubapp/pubs.asp
Buscar por (Keyword Search): pharmacoeconomics. Bajar el artículo usando Adobe Acrobat Reader 

Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996 Aug 3;313(7052):275-83. 
http://www.bmj.com/cgi/content/full/313/7052/275

Palmer S, Raftery J. Economics notes: Opportunity cost. BMJ 1999;318:1551-1552 ( 5 June ).
http://www.bmj.com/cgi/content/full/318/7197/1551

Raftery J. Economics notes: Costing in economic evaluation. BMJ 2000; 320: 1597. 
http://www.bmj.com/cgi/content/full/320/7249/1597

Torgerson DJ, Spencer A. Marginal costs and benefits. BMJ 1996 Jan 6;312(7022):35-6
http://www.bmj.com/cgi/content/full/312/7022/35

Torgerson DJ, Raftery J. Economics notes: Discounting. BMJ 1999; 319: 914-915. (2 October) 
http://www.bmj.com/cgi/content/full/319/7214/914

Byford S, Torgerson DJ, Raftery J. Economic Notes: Cost of illness studies. BMJ 2000 May 13;320(7245):1335.
http://www.bmj.com/cgi/content/full/320/7245/1335

Moore JL. Cost-Benefit Analysis: Issues in Its Use in Regulation Congressional Research Service. Report for Congress. June 28, 1995.
http://www.cnie.org/nle/rsk-4.html

Hill SR, Mitchell AS, Henry DA. Problems With the Interpretation of Pharmacoeconomic Analyses: A Review of Submissions to the Australian Pharmaceutical Benefits Scheme. JAMA. 2000; Vol. 283 No. 16, April 26, 2000;283: 2116-2121
http://jama.ama-assn.org/issues/v283n16/rfull/joc91361.html

Jones AJ, Sanchez LA. Pharmacoeconomic Evaluation: Applications in Managed Health Care Formulary Decision-Making. Drug Benefit Trends 7(9):12,15,19-22,32-34, 1995. Medscape 
http://www.medscape.com/SCP/DBT/1995/v07.n09/d114.sanchez/d114.sanchez.html

Langley PC, Sullivan SD. Pharmacoeconomic Evaluations: Guidelines for Drug Purchasers. Journal of Managed Care Pharmacy, 2(6), November/December 1996. 
http://www.amcp.org/jmcp/vol2/num6/eval.html

Milkovich G. Rational Formulary Decisions Based on Pharmacoeconomic Analysis.
http://www.sfhs.edu/critint/v5_n3/milkovic.htm

Richardson WS, Detsky AS. Users' Guides to the Medical Literature: VII. How to Use a Clinical Decision Analysis. A. Are the Results of the Study Valid? JAMA. 73(16):1292-1295, Apr 26, 1995.
No está disponible en el Internet, ir a la biblioteca! 

Richardson WS, Detsky AS. Users' Guides to the Medical Literature: VII. How to Use a Clinical Decision Analysis: B. What Are the Results and Will They Help Me In Caring for My Patients? JAMA. 273(20):1610-1613, May 24, 1995.
No está disponible en el Internet, ir a la biblioteca! 

Task Force on Principles for Economic Analysis of Health Care Technology. Economic Analysis of Health Care Technology: A Report on Principles. [Report] Annals of Internal Medicine. 123(1):61-70, 1995 July 1.
No está disponible en el Internet, ir a la biblioteca! 

Friedberg, Mark BA. Saffran, Bernard PhD. Stinson, Tammy J. MS. Nelson, Wendy PhD. Bennett, Charles L. MD, PhD. Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology. [Article] JAMA. 282(15):1453-1457, October 20, 1999. 
http://jama.ama-assn.org/issues/v282n15/rfull/joc91257.html

Barber, Julie A. Thompson, Simon G. Analysis and interpretation of cost data in randomized controlled trials: review of published studies. [Article] BMJ. 317(7167):1195-1200, October 31, 1998 
http://bmj.com/cgi/content/full/317/7167/1195

Shortell, Stephen M. PhD. Waters, Teresa M. PhD. Clarke, Kenneth W. B. MHA, MBA. Budetti, Peter P. MD, JD. Physicians as Double Agents: Maintaining Trust in an Era of Multiple Accountabilities. [Miscellaneous Article] JAMA. 280(12):1102-1108, September 23/30, 1998
http://jama.ama-assn.org/issues/v280n12/rfull/jpp80003.html

Christopher Evans, Ellen M. Dukes, Bruce Crawford. The Role of Pharmacoeconomic Information in the Formulary Decision-Making Process. J Managed Care Pharm 6(2):108-121. 
http://www.amcp.org/jmcp/vol6/num2/feature2.pdf
Bajar el artículo usando Adobe Acrobat Reader. 

Pharmaceutical Research and Manufacturers of America. Methodological and Conduct Principles for Pharmacoeconomic Research. [Drug Benefit Trends 8(2):28-32, 34, 1996. SCP Communications, Inc.].
http://www.medscape.com/SCP/DBT/1996/v08.n02/d257.phrma/d257.phrma.html